Voice Health Daily Scan — Disease Detection from 30 Seconds of Speech
Discovery Lens
C Combination Innovation
Two separate worlds finally connect — and the intersection is a product
One-Liner
Daily 30-second voice check that tracks vocal biomarkers over time and flags potential health changes. Software-only, runs on any phone.
Kill Reason
The FDA would likely classify a continuous voice-based disease detection tool as a Class II or III medical device, requiring clinical validation trials that cost $10M+ and take 3-5 years — an insurmountable barrier for an early-stage startup. Meanwhile Apple is actively researching voice biomarkers for Apple Watch, making this a feature race against a trillion-dollar incumbent.
What do you think?
Related ideas you can explore free:
killed: Urine and stool analysis for glucose monitoring, cancer screening, and kidney function markers falls squarely into FDA Class II/III medical device territory, requiring clinical trials and 510(k) or PMA approval costing millions and taking years. The entire high-value use case — the reason anyone would buy this — is legally undeliverable without regulatory clearance the product cannot realistically obtain.
killed: Amazon Alexa Together and comparable remote family monitoring services already serve this exact use case at consumer price points with embedded distribution advantages that a standalone WiFi sensing module cannot overcome. Daily routine monitoring and anomaly alerting for elderly relatives is a feature, not a product, in the current competitive landscape.
killed: Personal injury narrative reports require specific medico-legal structure, but the format is well-documented in public templates and any chiropractor with a configured AI prompt can replicate the output — there is no proprietary data asset, workflow lock-in, or network effect to justify a subscription fee against a commodity capability.